Morocco vs Saudi Arabia: Access to anti-retroviral drugs, female
Morocco
93.0%
in 2024
Saudi Arabia
91.0%
in 2024
Morocco rank
22nd
Saudi Arabia rank
25th
Access to anti-retroviral drugs, female over time
- Morocco
- Saudi Arabia
How they compare
Morocco currently reports 93.0% against 91.0% in Saudi Arabia, a difference of 2.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Saudi Arabia ahead.
Morocco ranks 22nd and Saudi Arabia ranks 25th of 141 countries.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Morocco | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.0% | 24.3% | 18.3% | Saudi Arabia |
| 2010s | 38.3% | 62.5% | 24.2% | Saudi Arabia |
| 2020s | 82.2% | 83.2% | 1.0% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Morocco or Saudi Arabia?
- Morocco, at 93.0% against 91.0% in Saudi Arabia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Morocco and Saudi Arabia?
- 2.0%, with Morocco ahead.
- How many years of comparable data are there for Morocco and Saudi Arabia?
- 25 years are reported by both, from 2000 to 2024.
- How do Morocco and Saudi Arabia rank globally for access to anti-retroviral drugs, female?
- Morocco ranks 22nd and Saudi Arabia ranks 25th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.